Status:
RECRUITING
cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas
Lead Sponsor:
Centre Jean Perrin
Conditions:
Locally Advanced Head and Neck Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this ancillary clinical trial is to evaluated circulating DNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carninoma. The ma...
Eligibility Criteria
Inclusion
- Selection Criteria:
- Patient included in NeckTAR study
- Written informed consent signed for NeckTAR-IN study
- Affiliation to the French social security system
Exclusion
Key Trial Info
Start Date :
October 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2031
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT07178847
Start Date
October 13 2025
End Date
July 1 2031
Last Update
December 1 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Jean PERRIN
Clermont-Ferrand, Puy-de-Dôme, France, 63011
2
Hôpital de la Croix-Rousse
Lyon, France
3
CHU de Saint-Étienne
Saint-Etienne, France